labs
Red Cell Distribution Width (RDW)
Sources
- 📄 2026-06-07 Ishamma T M 1
- 📄 2026-06-01 Ishamma T M
- 📄 2026-05-29 Ishamma T M 1
- 📄 Ishamma T M 1 5-27-2
- 📄 Ishamma T M 5-27-1
- 📄 2026-05-29 Ishamma T M
- 📄 Ishamma T M 5-27
- 📄 2026-05-17 Ishamma T M 1
- 📄 2026-05-11 Ishamma T M A
- 📄 2026-05-04 Ishamma T M
- 📄 Ishamma T M 1 ok
- 📄 Ishamma T M today
- 📄 Ishamma T M 1
- 📄 Ishamma T M
- 📄 Ishamma T M 2
- 📄 Ishamma T M 1 2
- 📄 Ishamma T M 1 3
- 📄 Ishamma T M 1 4
- 📄 Ishamma T M 3
- 📄 Ishamma T M 4
- 📄 Ishamma T M 5
- 📄 Report For Accession No 4170ZB001398 MYSRLIN
- 📄 4170ZB0011814170 849900t
- 📄 Ishamma 1
- 📄 Ishamma T M 6
- 📄 Ishamma T M 1 5
- 📄 Ishamma T M 7
- 📄 Ishamma T M 1 6
- 📄 Ishamma T M 8
- 📄 Ishamma T M 9
- 📄 Ishamma T M 1 7
- 📄 Ishamma T M 10
- 📄 File1000384802
- 📄 CCR 4182YK007572 296266q
- 📄 4182VI0131054182 816476x
Red Cell Distribution Width (RDW)
Longitudinal Data
| Date | Value (%) | Flag | Source |
|---|---|---|---|
| 2026-06-06 | 17.2 | H | KIMS — raw/labs/2026-06-07_Ishamma_T_M_1.pdf. IMPROVED −1.1 from June 1. Anisocytosis decreased but still elevated (ref 11.60-13.70). |
| 2026-06-01 | 18.3 | H | KIMS — raw/labs/2026-06-01_Ishamma_T_M.pdf. Persistent anisocytosis. +0.5 from May 27. Ties with Jan 25/31 and May 4 as second highest recorded. |
| 2026-05-27 | 17.8 | H | KIMS — raw/labs/20260527_Ishamma T M 1 5-27-2.pdf. Persistent anisocytosis. Stable, same as May 17. |
| 2026-05-23 | 18.0 | H | KIMS — raw/labs/20260527_Ishamma T M 5-27-1.pdf. Persistent anisocytosis. |
| 2026-05-17 | 17.8 | H | KIMS — raw/labs/2026-05-17_Ishamma_T_M_1.pdf. Persistent anisocytosis. Slight improvement from May 11. |
| 2026-05-11 | 18.2 | H | KIMS — raw/labs/2026-05-11_Ishamma_T_M_A.pdf. Persistent anisocytosis. Stable from May 4. |
| 2026-05-04 | 18.3 | H | KIMS — raw/assets/2026-05-04_Ishamma_T_M.pdf. Persistent anisocytosis. Slightly improved from Apr 27. |
| 2026-04-27 | 18.6 | H | KIMS — raw/labs/20260427_Ishamma T M 1 ok.pdf. Ties with Mar 18 as second highest. |
| 2026-04-20 | 17.6 | H | KIMS — 20260420_Ishamma T M today.pdf |
| 2026-04-13 | 17.7 | H | KIMS |
| 2026-04-06 | 18.1 | H | KIMS |
| 2026-03-30 | 17.8 | H | KIMS |
| 2026-03-25 | 18.1 | H | KIMS |
| 2026-03-18 | 18.6 | H | KIMS — second highest recorded |
| 2026-03-12 | 17.2 | H | KIMS |
| 2026-03-05 | 17.3 | H | KIMS |
| 2026-03-02 | 17.3 | H | KIMS — Cycle 3 start |
| 2026-02-25 | 17.2 | H | KIMS |
| 2026-02-23 | 16.8 | H | DDRC |
| 2026-02-20 | 16.7 | H | DDRC Agilus |
| 2026-02-17 | 17.3 | H | KIMS |
| 2026-02-10 | 17.6 | H | KIMS |
| 2026-02-04 | 18.2 | H | KIMS |
| 2026-01-31 | 18.3 | H | KIMS |
| 2026-01-28 | 18.2 | H | KIMS |
| 2026-01-25 | 18.3 | H | KIMS |
| 2026-01-22 | 18.8 | H | KIMS |
| 2026-01-19 | 19.4 | H | KIMS — highest recorded |
| 2026-01-16 | 19.1 | H | KIMS |
| 2025-11-28 | 17.2 | H | KIMS |
| 2025-11-19 | 17.3 | H | DDRC |
| 2022-09-27 | 16.6 | H | DDRC SRL |
Trend Analysis
RDW has been persistently elevated throughout the documented period (16.6–19.1%), indicating significant anisocytosis (variation in red blood cell size). The elevation predates the AML diagnosis (16.6% in September 2022), suggesting longstanding red cell size heterogeneity.
Elevated RDW in the context of macrocytosis (see Mcv) and Anemia is consistent with the underlying Aml and ongoing myelosuppressive chemotherapy effects. The combination of high MCV and high RDW points to a mixed population of red blood cells — some macrocytic, with overall size variability.